Ozem
  • Home
  • About
Sign in Subscribe

Latest

Patients taking weight-loss drugs often make 5 critical mistakes, doctor warns - Fox News — Photo by Moe Magners on Pexels

semaglutide

Avoiding the Top Six GLP‑1 Weight‑Loss Mistakes: A First‑Time User Guide

“Semaglutide cuts 15% of body weight in a year - if patients stick to the schedule,” the 2024 STEP 1 follow-up reported, highlighting that the drug’s promise collapses when real-world dosing goes off-track. In the past six months U.S. prescriptions have surged 42%, but a parallel rise in

26 Apr 2026
Novo Nordisk Expands GLP-1 Reach With Pediatric Oral Semaglutide Data - Yahoo Finance — Photo by StockRadars Co., on Pexels

semaglutide

Oral Semaglutide Cuts HbA1c by 30% in Teens - A Pill‑First Option for Pediatric Type 2 Diabetes

Headline: Oral semaglutide slashes HbA1c by 30% in teens, opening the door to a pill-first strategy for pediatric type 2 diabetes. In a 2024 Novo Nordisk-sponsored phase-III study, 1,200 kids aged 10-17 saw average HbA1c drop from 9.2% to 6.4% in just six months, while gaining a

26 Apr 2026
ACP 2026 Recap for Primary Care: Mammography, AI Scribes, and Obesity Medications - Patient Care Online — Photo by www.kaboom

semaglutide

Rural Primary Care in 2026: How AI Scribes, New Guidelines, and GLP‑1s Are Redrawing the Daily Playbook

Hook: Imagine a rural clinic where the electronic health record whispers the right CPT code, the AI scribe drafts a note faster than a coffee break, and the weight-loss drug works like a thermostat that nudges hunger down a notch. That’s not a sci-fi sketch; it’s the emerging

26 Apr 2026
See all
Ozem
  • Sign up
  • Privacy Policy
  • Terms & Conditions
Powered by Ghost

Ozem

Your trusted source for weight loss drugs, GLP-1 treatments, and metabolic health. Ozem offers well-researched articles and practical strategies.